Introgen Therapeutics, Inc. Presents ADVEXIN Biomarker Data at Major Cancer Conference

LOS ANGELES--(BUSINESS WIRE)--Introgen Therapeutics, Inc. (NASDAQ:INGN) reported updated ADVEXIN® biomarker data over the weekend in Los Angeles, California at the Annual Meeting of the American Association for Cancer Research.